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ABSTRACT
The dystroglycan complex (DGC) is a latticework of cell membrane proteins that provide a mechanical
link to the cytoskeleton and initiate cell signaling that provides integrity, regulates protein turnover,
stimulates growth, etc. Caveolin-3 has been identified as a muscle-specific isoform of the caveolin family
of proteins, and in skeletal muscle, caveolin-3 is localized in caveolae within the sarcolemma. Evidence
from Duchenne and Limb-Girdle Muscular Dystrophies suggests the involvement of caveolin-3 and
reactive oxygen species (ROS) in the disruption of the DGC and thus myopathy. We examined ROS as
upstream activators of caveolin-3 sarcolemmal localization in skeletal muscle during disuse atrophy.
EUK-134, a catalytic mimetic of superoxide dismutase (SOD) and catalase that degrades superoxide and
hydrogen peroxide, was administered to hindlimb unloaded, fully mature rats, 24 hours prior to and
during 54 hours of mechanical unloading. We observed that disuse-induced ROS production, using 4hydroxynonenal as a marker, was accompanied by elevated localization of caveolin-3 in the sarcolemma
and fiber atrophy in the unloaded group. In contrast, the unloaded+EUK-134 treatment group resulted in
less caveolin-3 localization at the sarcolemma, attenuation of oxidative stress, and mitigation of muscle
fiber atrophy. These results suggest that the increased sarcolemmal localization of caveolin-3 following
mechanical unloading is redox dependent. Our findings imply that ROS play an important role in the
early signaling events of mechanical unloading that elicit muscle atrophy. Our data also offer the
prospect that targeted antioxidants such as the EUK family of drugs could have therapeutic potential
during inactivity or other forms of myopathy.
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